Your session is about to expire
← Back to Search
Slower MRI Machine Entry for Vertigo
N/A
Recruiting
Led By Bryan Ward, MD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during mri up to 6 minutes
Awards & highlights
No Placebo-Only Group
Summary
This trial will look at how slower entry into MRI machines can reduce the symptoms of vertigo, dizziness, and imbalance.
Who is the study for?
This trial is for people who are scheduled to have an MRI scan at a high-strength magnet (7 Tesla). They must not have pacemakers, defibrillators, metal implants, cochlear implants, or ferromagnetic clips in the brain. Pregnant individuals and those with severe claustrophobia or any contraindications from the standard MRI questionnaire cannot participate.
What is being tested?
The study tests if entering the strong magnetic field of an MRI machine more slowly can reduce vertigo and dizziness. Normally patients enter in 20 seconds; this will be extended to one, two, or three minutes. Participants' feelings of dizziness will be recorded as they go into and come out of the MRI.
What are the potential side effects?
There may not be direct side effects from participating in this trial since it involves changing how quickly you enter the magnetic field rather than taking medication. However, participants might still experience varying levels of vertigo or dizziness.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ during mri up to 6 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during mri up to 6 minutes
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Prevalence of vertigo symptoms
Secondary study objectives
Duration (seconds) of Vertigo
Intensity of Vertigo
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: 3-minute entryExperimental Treatment1 Intervention
The participant will undergo an MRI scan using a slower rate of entry than that specified by the manufacturer. This rate of entry is three minutes (180 seconds).
Group II: 2-minute entryExperimental Treatment1 Intervention
The participant will undergo an MRI scan using a slower rate of entry than that specified by the manufacturer. This rate of entry is two minutes (120 seconds).
Group III: 1-minute entryExperimental Treatment1 Intervention
The participant will undergo an MRI scan using a slower rate of entry than that specified by the manufacturer. This rate of entry is one minute (60 seconds).
Group IV: Standard DurationActive Control1 Intervention
The participant will undergo an MRI scan using the manufacturer's rate of entry into and exit from the MRI machine. This rate of entry and exit is 20 seconds.
Find a Location
Who is running the clinical trial?
Johns Hopkins UniversityLead Sponsor
2,339 Previous Clinical Trials
14,881,573 Total Patients Enrolled
3 Trials studying Dizziness
287 Patients Enrolled for Dizziness
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
361 Previous Clinical Trials
181,958 Total Patients Enrolled
6 Trials studying Dizziness
88,457 Patients Enrolled for Dizziness
Bryan Ward, MDPrincipal InvestigatorJohns Hopkins University